Ftse Mib
34.465,68
-0,40%
DAX
18.680,20
-0,25%
S&P 500
5.320,83
-0,01%
NASDAQ
16.824,22
-0,05%
Bitcoin
70.401,70
0,39%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Poseida Therapeutics Inc (PSTX) Poseida Therapeutics Inc (PSTX) Notizie

PSTX

Poseida Therapeutics (PSTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PSTX
DataOraFonteTitoloSimboloCompagnia
14/05/202422:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSTXPoseida Therapeutics Inc
14/05/202422:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTXPoseida Therapeutics Inc
14/05/202422:05PR Newswire (US)Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024NASDAQ:PSTXPoseida Therapeutics Inc
09/05/202415:00PR Newswire (US)Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual MeetingNASDAQ:PSTXPoseida Therapeutics Inc
06/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSTXPoseida Therapeutics Inc
02/05/202403:30PR Newswire (US)Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in OncologyNASDAQ:PSTXPoseida Therapeutics Inc
01/05/202421:25AllPennyStocks.comBiotech Soars on Research Collaboration And License Agreement ReleaseNASDAQ:PSTXPoseida Therapeutics Inc
18/04/202414:00PR Newswire (US)Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:PSTXPoseida Therapeutics Inc
17/04/202415:00PR Newswire (US)Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline FocusNASDAQ:PSTXPoseida Therapeutics Inc
08/04/202418:00PR Newswire (US)Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple MyelomaNASDAQ:PSTXPoseida Therapeutics Inc
01/04/202422:05PR Newswire (US)Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSTXPoseida Therapeutics Inc
25/03/202421:05PR Newswire (US)Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical OfficerNASDAQ:PSTXPoseida Therapeutics Inc
19/03/202421:05PR Newswire (US)Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:PSTXPoseida Therapeutics Inc
13/03/202421:05PR Newswire (US)Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple MyelomaNASDAQ:PSTXPoseida Therapeutics Inc
07/03/202422:07PR Newswire (US)Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023NASDAQ:PSTXPoseida Therapeutics Inc
04/03/202423:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTXPoseida Therapeutics Inc
08/02/202422:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PSTXPoseida Therapeutics Inc
04/01/202414:00PR Newswire (US)Poseida Therapeutics Highlights Recent Progress, Strategic Priorities and Anticipated 2024 Key MilestonesNASDAQ:PSTXPoseida Therapeutics Inc
11/12/202316:31Dow Jones NewsPoseida Therapeutics Shares Climb on Positive Data for Blood Cancer TreatmentNASDAQ:PSTXPoseida Therapeutics Inc
10/12/202318:00PR Newswire (US)Poseida Therapeutics Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:PSTXPoseida Therapeutics Inc
09/11/202322:05PR Newswire (US)Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2023NASDAQ:PSTXPoseida Therapeutics Inc
07/11/202314:00PR Newswire (US)Poseida Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:PSTXPoseida Therapeutics Inc
02/11/202314:01PR Newswire (US)Poseida Therapeutics to Present at the 65th ASH Annual Meeting and ExpositionNASDAQ:PSTXPoseida Therapeutics Inc
09/10/202322:30PR Newswire (US)Poseida Therapeutics Announces Leadership TransitionNASDAQ:PSTXPoseida Therapeutics Inc
14/08/202322:41Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:PSTXPoseida Therapeutics Inc
11/08/202322:48Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PSTXPoseida Therapeutics Inc
08/08/202322:05PR Newswire (US)Poseida Therapeutics Provides Financial Results for the Second Quarter of 2023NASDAQ:PSTXPoseida Therapeutics Inc
07/08/202316:41Dow Jones NewsPoseida Therapeutics Shares Leap on Astellas InvestmentsNASDAQ:PSTXPoseida Therapeutics Inc
07/08/202315:58Dow Jones NewsPoseida Therapeutics in $50 Million Investment Deal With AstellasNASDAQ:PSTXPoseida Therapeutics Inc
07/08/202315:01PR Newswire (US)Poseida Therapeutics Announces Strategic Investment by Astellas and Provides Business UpdateNASDAQ:PSTXPoseida Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PSTX

La tua Cronologia

BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
G
Generali
BIT
SRG
Snam
BIT
BAMI
Banco BPM
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network